20.17
price up icon3.49%   0.68
pre-market  Vorhandelsmarkt:  19.97   -0.20   -0.99%
loading

Enliven Therapeutics Inc Aktie (ELVN) Neueste Nachrichten

pulisher
Dec 10, 2025

Top investors say Enliven Therapeutics Inc (ELVN) ticks everything they need - Setenews

Dec 10, 2025
pulisher
Dec 09, 2025

Enliven Therapeutics (ELVN): Evaluating Valuation After a Recent Share Price Rebound and Ongoing Clinical Progress - Yahoo Finance

Dec 09, 2025
pulisher
Dec 09, 2025

Enliven Therapeutics, Inc. (NASDAQ:ELVN) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World

Dec 09, 2025
pulisher
Dec 08, 2025

Trading the Move, Not the Narrative: (ELVN) Edition - news.stocktradersdaily.com

Dec 08, 2025
pulisher
Dec 08, 2025

Enliven Therapeutics: ENABLE trial shows promise in treating atypical fusion CML - Traders Union

Dec 08, 2025
pulisher
Dec 08, 2025

Enliven Therapeutics, Inc. (NASDAQ:ELVN) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Dec 08, 2025
pulisher
Dec 07, 2025

Will Enliven Therapeutics Inc stock benefit from AI adoptionJuly 2025 Setups & Long-Term Capital Growth Strategies - BỘ NỘI VỤ

Dec 07, 2025
pulisher
Dec 06, 2025

Affinity Asset Advisors LLC Buys Shares of 400,000 Enliven Therapeutics, Inc. $ELVN - MarketBeat

Dec 06, 2025
pulisher
Dec 06, 2025

Enliven Therapeutics (NASDAQ:ELVN) and PreveCeutical Medical (OTCMKTS:PRVCF) Head-To-Head Analysis - Defense World

Dec 06, 2025
pulisher
Dec 05, 2025

Can Enliven Therapeutics Inc. stock deliver surprise earnings beatTrade Analysis Report & Free Low Drawdown Momentum Trade Ideas - Newser

Dec 05, 2025
pulisher
Dec 03, 2025

Wall Street Analysts Believe Enliven Therapeutics, Inc. (ELVN) Could Rally 101.26%: Here's is How to Trade - sharewise.com

Dec 03, 2025
pulisher
Dec 03, 2025

Ready to Jump After Recent Trade: Enliven Therapeutics Inc (ELVN) - Setenews

Dec 03, 2025
pulisher
Dec 03, 2025

Will Enliven Therapeutics Inc. stock keep outperforming rivals2025 Price Targets & Long-Term Capital Growth Strategies - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

Is Enliven Therapeutics Inc. stock ready for breakout2025 Volume Leaders & Long-Term Growth Stock Strategies - Newser

Dec 03, 2025
pulisher
Dec 02, 2025

Enliven Therapeutics (NASDAQ:ELVN) Shares Down 8%Time to Sell? - MarketBeat

Dec 02, 2025
pulisher
Dec 01, 2025

Geode Capital Management LLC Grows Position in Enliven Therapeutics, Inc. $ELVN - MarketBeat

Dec 01, 2025
pulisher
Dec 01, 2025

Franklin Resources Inc. Has $8.63 Million Stock Holdings in Enliven Therapeutics, Inc. $ELVN - MarketBeat

Dec 01, 2025
pulisher
Nov 29, 2025

Risks Report: Will Enliven Therapeutics Inc. stock benefit from AI adoption2025 Macro Impact & Smart Swing Trading Alerts - BỘ NỘI VỤ

Nov 29, 2025
pulisher
Nov 29, 2025

Will Enliven Therapeutics Inc. stock gain from strong economy2025 Fundamental Recap & Weekly Breakout Watchlists - BỘ NỘI VỤ

Nov 29, 2025
pulisher
Nov 29, 2025

Does Enliven Therapeutics, Inc. (ELVN) Have the Potential to Rally 87.49% as Wall Street Analysts Expect? - MSN

Nov 29, 2025
pulisher
Nov 27, 2025

(ELVN) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com

Nov 27, 2025
pulisher
Nov 26, 2025

Enliven Therapeutics Inc (ELVN) is looking forward to a strong quarter - Setenews

Nov 26, 2025
pulisher
Nov 26, 2025

SG Americas Securities LLC Buys 23,261 Shares of Enliven Therapeutics, Inc. $ELVN - MarketBeat

Nov 26, 2025
pulisher
Nov 25, 2025

Enliven Therapeutics targets CML drug resistance breakthrough - Traders Union

Nov 25, 2025
pulisher
Nov 22, 2025

Enliven Therapeutics (NASDAQ:ELVN) Insider Sells $279,125.00 in Stock - MarketBeat

Nov 22, 2025
pulisher
Nov 21, 2025

Enliven Therapeutics Insider Sold Shares Worth $279,155, According to a Recent SEC Filing - MarketScreener

Nov 21, 2025
pulisher
Nov 21, 2025

Officer Lyssikatos Sells 12,500 ($279.2K) Of Enliven Therapeutics Inc [ELVN] - TradingView

Nov 21, 2025
pulisher
Nov 21, 2025

[Form 4] Enliven Therapeutics, Inc. Insider Trading Activity - Stock Titan

Nov 21, 2025
pulisher
Nov 21, 2025

Will Enliven Therapeutics Inc. stock outperform international peersWeekly Market Report & AI Enhanced Trade Execution Alerts - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

How Enliven Therapeutics Inc. stock reacts to Fed rate cutsGlobal Markets & Daily Technical Forecast Reports - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Why Enliven Therapeutics Inc. stock is favored by pension fundsWall Street Watch & Low Drawdown Investment Ideas - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

What hedge fund activity signals for Enliven Therapeutics Inc. stock2025 Market Outlook & Weekly Top Gainers Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Samuel Kintz Sells 12,500 Shares of Enliven Therapeutics (NASDAQ:ELVN) Stock - MarketBeat

Nov 20, 2025
pulisher
Nov 19, 2025

Is Enliven Therapeutics Inc. stock positioned well for digital economyMarket Risk Analysis & Expert-Curated Trade Recommendations - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Enliven Therapeutics Inc. stock a contrarian buy2025 Investor Takeaways & AI Powered Market Entry Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Enliven Therapeutics CEO Kintz sells $272k in shares By Investing.com - Investing.com Canada

Nov 19, 2025
pulisher
Nov 19, 2025

CEO Kintz Sells 12,500 ($272.7K) Of Enliven Therapeutics Inc [ELVN] - TradingView

Nov 19, 2025
pulisher
Nov 19, 2025

Shareholder Lyssikatos Revocable Trust 12/15/11 Files To Sell 12,500 Of Enliven Therapeutics Inc [ELVN] - TradingView

Nov 19, 2025
pulisher
Nov 19, 2025

What analyst consensus says on Enliven Therapeutics Inc. stockJuly 2025 Analyst Calls & Free Fast Gain Swing Trade Alerts - newser.com

Nov 19, 2025
$38.26
price up icon 0.45%
$95.17
price up icon 0.01%
$31.24
price up icon 1.00%
$95.73
price down icon 0.12%
biotechnology ONC
$322.68
price up icon 1.25%
$189.85
price down icon 2.22%
Kapitalisierung:     |  Volumen (24h):